Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

XOMA Royalty (XOMA) Cash & Equivalents (2016 - 2025)

XOMA Royalty (XOMA) has disclosed Cash & Equivalents for 11 consecutive years, with $34.8 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 65.8% to $34.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34.8 million through Dec 2025, down 65.8% year-over-year, with the annual reading at $34.8 million for FY2025, 65.8% down from the prior year.
  • Cash & Equivalents hit $34.8 million in Q4 2025 for XOMA Royalty, down from $45.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $143.9 million in Q2 2024 to a low of $28.0 million in Q3 2023.
  • Historically, Cash & Equivalents has averaged $75.8 million across 5 years, with a median of $76.7 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 407.32% in 2024 and later plummeted 68.19% in 2025.
  • Year by year, Cash & Equivalents stood at $93.3 million in 2021, then crashed by 38.04% to $57.8 million in 2022, then crashed by 50.97% to $28.4 million in 2023, then skyrocketed by 258.54% to $101.7 million in 2024, then tumbled by 65.8% to $34.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for XOMA at $34.8 million in Q4 2025, $45.2 million in Q3 2025, and $75.1 million in Q2 2025.